Ad is loading...
FISVX
Price
$27.03
Change
-$0.25 (-0.92%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

FISVX vs VISVX

Header iconFISVX vs VISVX Comparison
Open Charts FISVX vs VISVXBanner chart's image
Fidelity Small Cap Value Index
Price$27.03
Change-$0.25 (-0.92%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
FISVX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FISVX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FISVX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. FISVX (1.27B). FISVX pays higher dividends than VISVX: FISVX (2.01) vs VISVX (1.90). FISVX was incepted earlier than VISVX: FISVX (5 years) vs VISVX (27 years). FISVX is a more actively managed with annual turnover of: 33.00 vs. VISVX (16.00). FISVX has a lower initial minimum investment than VISVX: FISVX (0) vs VISVX (3000). FISVX (29.54) and VISVX (28.71) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. FISVX (40.04).
FISVXVISVXFISVX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years27 years-
Gain YTD13.01015.43384%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B57.6B2%
Annual Yield % from dividends2.011.90106%
Returns for 1 year29.5428.71103%
Returns for 3 years4.1213.2331%
Returns for 5 years40.0457.3270%
Returns for 10 yearsN/A108.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics